Biotechnology
Hong Kong companies specializing in biotechnology
Biotechnology firms research and develop new medical therapies or agricultural processes. Clinical trial outcomes and regulatory decisions routinely drive extreme price action and liquidity across this industry. Currently, Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H ranks as the top gainer, and BrainAurora Medical Technology Limited sees maximum volume. The technical and fundamental metrics provided below help quantify these sudden shifts.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 198.92 B HKD | 47.62 HKD | −2.18% | 41.35 M | 1.19 | 35.75 | 1.33 HKD | +24.96% | 0.00% | Health technology | Strong buy | |
| 95.94 B HKD | 8.450 HKD | −1.52% | 94.58 M | 0.98 | 11.48 | 0.74 HKD | +103.65% | 3.95% | Health technology | Buy | |
| 77.27 B HKD | 30.38 HKD | −9.80% | 47.74 M | 0.92 | — | −2.29 HKD | −120.02% | 0.00% | Health technology | Strong buy | |
| 45.64 B HKD | 39.08 HKD | −5.15% | 2.33 M | 1.73 | — | −0.54 HKD | −169.67% | 0.36% | Health technology | Buy | |
| 37.45 B HKD | 15.18 HKD | −1.04% | 15.09 M | 0.74 | 4.15 | 3.65 HKD | +254.77% | 1.69% | Health technology | Strong buy | |
| 35.52 B HKD | 23.76 HKD | −3.10% | 3.9 M | 0.55 | 13.35 | 1.78 HKD | +442.43% | 0.57% | Health technology | Buy | |
| 26.26 B HKD | 6.125 HKD | −3.85% | 35.31 M | 0.83 | — | −0.06 HKD | +6.86% | 0.00% | Health technology | Buy | |
| 22.85 B HKD | 38.80 HKD | −1.67% | 222.19 K | 0.91 | — | −0.56 HKD | +25.03% | 0.00% | Health technology | No rating | |
| 22.49 B HKD | 18.36 HKD | +1.05% | 6.14 M | 1.33 | — | −1.33 HKD | +16.86% | 0.00% | Health technology | Strong buy | |
| 13 B HKD | 26.68 HKD | −1.69% | 2.77 M | 0.70 | 190.44 | 0.14 HKD | — | 0.00% | Health technology | Strong buy | |
| 11.64 B HKD | 152.2 HKD | +1.81% | 146.25 K | 3.90 | — | — | — | 0.00% | Health technology | Buy | |
| 10.03 B HKD | 104.9 HKD | −5.67% | 740.44 K | 0.34 | — | −17.97 HKD | — | 0.00% | Health technology | Strong buy | |
| 7.26 B HKD | 36.56 HKD | −4.19% | 632.9 K | 0.62 | — | −1.53 HKD | +6.66% | 0.00% | Health technology | Strong buy | |
| 6.38 B HKD | 6.255 HKD | −6.01% | 802 K | 0.70 | — | −0.20 HKD | −178.45% | 0.00% | Health technology | Buy | |
| 22335Shaanxi Micot Pharmaceutical Technology Co., Ltd. Class H | 5.16 B HKD | 18.81 HKD | +15.19% | 11.81 M | 1.66 | — | −1.25 HKD | −249.94% | 0.00% | Health technology | Strong buy |
| 4.8 B HKD | 4.550 HKD | −7.05% | 2.46 M | 1.00 | — | −0.66 HKD | −130.04% | 0.00% | Health technology | Strong buy | |
| 99637Alebund Pharmaceuticals (Jiangsu) Limited Class H | 4.1 B HKD | 19.18 HKD | +3.84% | 667.42 K | 0.79 | — | −2.40 HKD | −103.44% | 0.00% | Health technology | Strong buy |
| 3.83 B HKD | 56.95 HKD | +2.89% | 122.9 K | 0.44 | — | −3.27 HKD | — | 0.00% | Health technology | Strong buy | |
| 3.74 B HKD | 4.660 HKD | −5.28% | 940.12 K | 1.13 | 6.15 | 0.76 HKD | — | 0.00% | Health technology | Buy | |
| 3.62 B HKD | 66.00 HKD | −5.71% | 38.9 K | 0.30 | — | — | — | 0.00% | Health technology | No rating | |
| 3.61 B HKD | 27.00 HKD | −3.09% | 22 K | 4.46 | — | −1.07 HKD | −22.56% | 0.00% | Health technology | No rating | |
| 3.37 B HKD | 14.33 HKD | −3.18% | 124.14 K | 0.95 | 5.26 | 2.72 HKD | — | 0.00% | Health technology | Buy | |
| 3.17 B HKD | 1.590 HKD | +0.63% | 916 K | 1.73 | 4.76 | 0.33 HKD | +651.58% | 0.00% | Health technology | No rating | |
| 3.07 B HKD | 15.36 HKD | −0.26% | 200 | 1.00 | — | −0.75 HKD | −3.19% | 0.00% | Health technology | No rating | |
| 2.94 B HKD | 27.34 HKD | −8.93% | 149.8 K | 1.53 | — | — | — | 0.00% | Health technology | Strong buy | |
| 2.76 B HKD | 19.82 HKD | −0.90% | 194.3 K | 1.30 | 14.99 | 1.32 HKD | +57.69% | 0.00% | Health technology | Neutral | |
| 2.69 B HKD | 6.050 HKD | −7.56% | 1.88 M | 1.63 | — | −0.27 HKD | +61.07% | 0.00% | Health technology | Strong buy | |
| 2.68 B HKD | 1.335 HKD | −1.48% | 7.24 M | 2.17 | 15.12 | 0.09 HKD | +13.94% | 0.00% | Health technology | No rating | |
| 2.48 B HKD | 8.085 HKD | −3.12% | 2.45 M | 0.51 | — | −0.74 HKD | −13.19% | 0.00% | Health technology | No rating | |
| 2.44 B HKD | 9.030 HKD | +0.17% | 10.28 M | 1.71 | — | −1.08 HKD | +15.73% | 0.00% | Health technology | Neutral | |
| 66132HJ Science Co., Ltd. Class H | 2.38 B HKD | 31.96 HKD | −3.27% | 98.2 K | 0.85 | — | — | — | 0.00% | Health technology | No rating |
| 1.97 B HKD | 7.500 HKD | −3.85% | 65 K | 0.55 | 9.96 | 0.75 HKD | −6.74% | 0.00% | Health technology | No rating | |
| 1.96 B HKD | 1.380 HKD | −4.50% | 194.48 M | 0.51 | — | −0.28 HKD | — | 0.00% | Health technology | No rating | |
| 1.84 B HKD | 5.835 HKD | −1.93% | 134.5 K | 0.53 | — | — | — | 0.00% | Health technology | Strong buy | |
| 1.83 B HKD | 1.560 HKD | +4.35% | 10.2 K | 0.09 | — | −0.60 HKD | −151.15% | 0.00% | Health technology | No rating | |
| 1.6 B HKD | 3.415 HKD | +1.34% | 37.6 M | 1.64 | — | −0.95 HKD | — | 0.00% | Health technology | No rating | |
| 1.41 B HKD | 1.000 HKD | −0.99% | 233.4 K | 0.33 | — | −0.15 HKD | −4.24% | 0.00% | Health technology | No rating | |
| 1.03 B HKD | 2.500 HKD | −6.02% | 546 K | 0.50 | — | −0.92 HKD | +43.84% | 0.00% | Health technology | No rating | |
| 741.2 M HKD | 1.040 HKD | +1.46% | 884 K | 0.90 | — | −0.27 HKD | +51.71% | 0.00% | Health technology | No rating | |
| 678.2 M HKD | 1.380 HKD | +4.94% | 1.12 M | 1.42 | — | −0.45 HKD | −8.86% | 0.00% | Health technology | No rating | |
| 467.7 M HKD | 4.175 HKD | +0.24% | 62.9 K | 2.69 | — | −0.87 HKD | +30.94% | 0.00% | Health technology | No rating | |
| 386.26 M HKD | 0.244 HKD | +7.49% | 110.15 K | 0.21 | — | −0.04 HKD | +83.97% | 0.00% | Health technology | No rating | |
| 259.44 M HKD | 3.095 HKD | −0.80% | 1.4 K | 0.13 | — | — | — | 0.00% | Health technology | No rating |